TGF-beta gene therapy (Gencell/CNRS)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameTGF-beta gene therapy (Gencell/CNRS)
Drug Alias NameTGF-beta gene therapy (Aventis Gencell/CNRS)TGF-beta gene therapy (RPR Gencell/CNRS)
ClassificationBiologics
Mechanisms of ActionTGF beta gene stimulantsNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCentelion SAS
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A